Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Forward Pharma A/S stock

Own Forward Pharma A/S stock in just a few minutes.

Forward Pharma A/S is a biotechnology business based in the US. Forward Pharma A/S shares (FWP) are listed on the NASDAQ and all prices are listed in US Dollars. Forward Pharma A/S employs 4 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Forward Pharma A/S

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – FWP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Forward Pharma A/S share price

Use our graph to track the performance of FWP stocks over time.

Forward Pharma A/S shares at a glance

Information last updated 2021-04-29.
52-week range$5.65 - $9.38
50-day moving average $7.09
200-day moving average $7.05
Wall St. target price$37.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.13

Buy Forward Pharma A/S shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Forward Pharma A/S stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Forward Pharma A/S under- or over-valued?

Valuing Forward Pharma A/S stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Forward Pharma A/S's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Forward Pharma A/S's PEG ratio

Forward Pharma A/S's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.13. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Forward Pharma A/S's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Forward Pharma A/S financials

Gross profit TTM $0
Return on assets TTM -2.68%
Return on equity TTM -8.26%
Profit margin 0%
Book value $11.41
Market capitalisation $51.6 million

TTM: trailing 12 months

Shorting Forward Pharma A/S shares

There are currently 1,407 Forward Pharma A/S shares held short by investors – that's known as Forward Pharma A/S's "short interest". This figure is 48.9% down from 2,754 last month.

There are a few different ways that this level of interest in shorting Forward Pharma A/S shares can be evaluated.

Forward Pharma A/S's "short interest ratio" (SIR)

Forward Pharma A/S's "short interest ratio" (SIR) is the quantity of Forward Pharma A/S shares currently shorted divided by the average quantity of Forward Pharma A/S shares traded daily (recently around 28140). Forward Pharma A/S's SIR currently stands at 0.05. In other words for every 100,000 Forward Pharma A/S shares traded daily on the market, roughly 50 shares are currently held short.

However Forward Pharma A/S's short interest can also be evaluated against the total number of Forward Pharma A/S shares, or, against the total number of tradable Forward Pharma A/S shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Forward Pharma A/S's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Forward Pharma A/S shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Forward Pharma A/S shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Forward Pharma A/S.

Find out more about how you can short Forward Pharma A/S stock.

Forward Pharma A/S share dividends

We're not expecting Forward Pharma A/S to pay a dividend over the next 12 months.

Have Forward Pharma A/S's shares ever split?

Forward Pharma A/S's shares were split on a 1:7 basis on 5 December 2019. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Forward Pharma A/S shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Forward Pharma A/S shares which in turn could have impacted Forward Pharma A/S's share price.

Forward Pharma A/S share price volatility

Over the last 12 months, Forward Pharma A/S's shares have ranged in value from as little as $5.65 up to $9.38. A popular way to gauge a stock's volatility is its "beta".

FWP.US volatility(beta: 1.61)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Forward Pharma A/S's is 1.6095. This would suggest that Forward Pharma A/S's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Forward Pharma A/S overview

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was incorporated in 2005 and is headquartered in Copenhagen, Denmark. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site